Genomics Market Dynamics and Developments by 2031
Historic Data: 2021-2022 | Base Year: 2023 | Forecast Period: 2024-2031Genomics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification, and Others), Product & Service (Instruments/Systems, Consumables, and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research, and Others) and End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, and Others), and Geography
- Report Date : Mar 2026
- Report Code : TIPTE100000730
- Category : Life Sciences
- Status : Data Released
- Available Report Formats :

- No. of Pages : 150
The Genomics Market size is projected to reach US$ 83.61 billion by 2031 from US$ 31.22 billion in 2023. The market is expected to register a CAGR of 13.1% in 2023–2031. Development of novel technologies in genomics and the use of artificial intelligence are likely to remain key genomics Market trends.
Genomics Market Analysis
Genomics is a field of molecular biology that studies the structure, function, evolution, and mapping of human genomes. It has various applications across fields such as personalized medicine, disease risk prediction, drug interaction studies, environmental microorganism exploration, biofuel generation, genealogical assessments, forensic science, and agriculture. Growing investments & funding in the field of genomics, an increasing number of start-ups is expected to favor the genomics market growth.
Genomics Market Overview
As highlighted by the Genomics Nation Report published in 2022 by the UK Bioindustry Association, companies in the field of genomics have raised a total of £1.85 (US$ 1.98) billion in venture investment, between 2017 and 2021. Out of which 39.2% of the funding was raised in 2021 alone. Specifically, genomic companies raised £718 (US$ 770.23) million in venture investment across 53 deals in 2021, which includes companies that exited during this period. Growing emphasis on research and development activities is contributing to the expansion of the genomics market.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Genomics Market: Strategic Insights
-
Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
GENOMICS Market Drivers and Opportunities
Cost Efficacy of Genome Sequencing Procedures to Favor Market
In recent years, next-generation sequencing prices have declined substantially. The rapid costs reduction helps in clinical research with a greater speed and at a lowered price point. This is likely to be enticing to help startups for the health of consumers. According to an article published in Frontiers in January 2022, a study observed a cohort of 6 neonatal intensive care unit (NICU) patients in the US diagnosed by rapid whole genome sequencing (rWGS) and showed a reduction in length of hospital stay by 124 days resulting in a combined inpatient cost savings of US$ 803,200 (~ $19,000 per infant).
Artificial Intelligence – An Opportunity in Personalized Medicine
The field of genomics has been transformed by the use of artificial intelligence. These technologies are assisting researchers and scientists in analyzing and interpreting vast amounts of genomic data. As a result, new discoveries are being made, and personalized medicine is advancing. AI-powered solutions for clinical genomics applications, such as genomic diagnostics, prognostics, and therapeutics, are transforming healthcare. AI and genomics are being utilized to detect genetic mutations and biomarkers linked to particular illnesses, allowing for the creation of personalized treatment strategies for patients.
Genomics Market Report Segmentation Analysis
Key segments that contributed to the derivation of the genomics market analysis are technology, product & service, application, and end user.
- Based on technology, the genomics market is divided into sequencing, microarray, PCR, nucleic acid extraction and purification, and others. The sequencing segment held a larger market share in 2023.
- By product & service, the market is segmented into instruments/systems, consumables, and services. The instruments/systems segment held the largest share of the market in 2023.
- In terms of application, the market is divided into diagnostics, drug discovery and development, precision/personalized medicine, agriculture & animal research, and others. The diagnostics segment dominated the market in 2023.
GENOMICS Market Share Analysis by Geography
The geographic scope of the genomics market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the genomics market. Factors such as the increasing incorporation of advanced sequencing methods in healthcare, extensive R&D activities by various academic and research institutes, and growing demand for DNA synthesis techniques from biopharmaceutical and biotechnology companies drive the growth of the genomics market in North America. Moreover, rising initiatives and fundings by the government for genome sequencing in precision medicine is further expected to stimulate market growth and contribute to exceptional revenue generation. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
Genomics Market Regional InsightsThe regional trends and factors influencing the Genomics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Genomics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Genomics Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 31.22 Billion |
| Market Size by 2031 | US$ 83.61 Billion |
| Global CAGR (2023 - 2031) | 13.1% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
Genomics Market Players Density: Understanding Its Impact on Business Dynamics
The Genomics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
- Get the Genomics Market top key players overview
Genomics Market News and Recent Developments
The genomics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the Genomics market:
- Illumina, Inc. and Sequoia Capital China partnered to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator. The company creation engine focused on building life sciences startup companies advancing breakthrough applications in genomics. (Source: Illumina, Inc, Company Website, 2021)
- Agilent Technologies introduced the SureSelect DNA Kit which addresses key challenges that laboratories encounter when preparing DNA sequencing libraries for their research. (Source: Agilent Technologies, Press Release, 2020)
Genomics Market Report Coverage and Deliverables
The “Genomics Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.
Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDsI requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future AnalyticaWe worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam GlobalThe Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK TechnologiesI wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample For